To improve decision-making in drug development, researchers need instruments that allow them to obtain high-quality kinetics data. The Creoptix WAVEsystem, based on GCI technology, provides label-free interaction analysis allowing you to obtain kinetic and affinity data, alongside evaluation of binding specificity, in real-time.
Download this whitepaper highlighting four case studies which demonstrated that the Creoptix WAVEsystem can:
- Determine the binding kinetics of 146 drug HIT compounds in hours
- Reduce HIT screening campaigns from weeks to days
- Provide you with sensitive and rapid label-free analysis
- Directly characterize antibodies from clinical blood plasma samples
- Screened crude-reaction mixtures (CRMs) for affinity with minimal sample purification